BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38453704)

  • 1. Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population.
    Gill EL; Gill CM; McEvoy C
    Ann Hematol; 2024 May; 103(5):1745-1752. PubMed ID: 38453704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. StenoSCORE: Predicting Stenotrophomonas maltophilia Bloodstream Infections in the Hematologic Malignancy Population.
    Karaba SM; Goodman KE; Amoah J; Cosgrove SE; Tamma PD
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0079321. PubMed ID: 34060899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stenotrophomonas maltophilia bloodstream infections in adult recipients of umbilical cord blood transplantation.
    Kimura M; Yamamoto H; Uchida N; Ogura S; Yamamuro R; Mitsuki T; Yuasa M; Kaji D; Kageyama K; Nishida A; Taya Y; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Wake A; Taniguchi S; Araoka H
    Transplant Cell Ther; 2021 Mar; 27(3):269.e1-269.e7. PubMed ID: 33781536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations.
    Cho SY; Lee DG; Choi SM; Park C; Chun HS; Park YJ; Choi JK; Lee HJ; Park SH; Choi JH; Yoo JH
    BMC Infect Dis; 2015 Feb; 15():69. PubMed ID: 25887489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical predictors of Stenotrophomonas maltophilia bacteremia in adult patients with hematologic malignancy.
    Kim SH; Cho SY; Kang CI; Seok H; Huh K; Ha YE; Chung DR; Lee NY; Peck KR; Song JH
    Ann Hematol; 2018 Feb; 97(2):343-350. PubMed ID: 29138886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Infection and Mortality Associated With Stenotrophomonas maltophilia Bloodstream Infections in Children; Comparison With Pseudomonas aeruginosa Bloodstream Infections.
    Bilen NM; Sahbudak Bal Z; Güner Özenen G; Yildirim Arslan S; Ozek G; Ozdemir Karadas N; Yazici P; Cilli F; Kurugöl Z
    Pediatr Infect Dis J; 2023 May; 42(5):374-380. PubMed ID: 36795557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive scoring system for distinguishing Stenotrophomonas maltophilia bacteremia from Pseudomonas aeruginosa bacteremia in patients with hematological malignancies.
    Sakoh T; Kimura M; Takagi S; Ogura S; Morishima M; Yamamuro R; Yamaguchi K; Yuasa M; Kaji D; Kageyama K; Taya Y; Nishida A; Ishiwata K; Yamamoto H; Yamamoto G; Asano-Mori Y; Wake A; Uchida N; Taniguchi S; Araoka H
    Ann Hematol; 2023 May; 102(5):1239-1246. PubMed ID: 36971808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bloodstream infection caused by Stenotrophomonas maltophilia in children.
    Kagen J; Zaoutis TE; McGowan KL; Luan X; Shah SS
    Pediatr Infect Dis J; 2007 Jun; 26(6):508-12. PubMed ID: 17529868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating antimicrobial duration for Gram-negative bacteremia in patients with neutropenia due to hematologic malignancy or hematopoietic stem cell transplantation.
    Ranganath N; Yetmar ZA; McCandless AR; Rivera CG; Lahr BD; Tande AJ; Shah AS
    Transpl Infect Dis; 2023 Oct; 25(5):e14085. PubMed ID: 37279240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early versus late onset bloodstream infection during neutropenia after high-dose chemotherapy for hematologic malignancy.
    Widmer AF; Kern WV; Roth JA; Dettenkofer M; Goetting T; Bertz H; Theilacker C;
    Infection; 2019 Oct; 47(5):837-845. PubMed ID: 31187401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriate antibiotic therapy is a predictor of outcome in patients with Stenotrophomonas maltophilia blood stream infection in the intensive care unit.
    Lai JJ; Siu LK; Chang FY; Lin JC; Yu CM; Wu RX; Wang CH
    J Microbiol Immunol Infect; 2023 Jun; 56(3):624-633. PubMed ID: 36948945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stenotrophomonas maltophilia bacteremia and pneumonia at a tertiary-care oncology center: a review of 16 years.
    Velázquez-Acosta C; Zarco-Márquez S; Jiménez-Andrade MC; Volkow-Fernández P; Cornejo-Juárez P
    Support Care Cancer; 2018 Jun; 26(6):1953-1960. PubMed ID: 29307014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia.
    Paez JI; Tengan FM; Barone AA; Levin AS; Costa SF
    Eur J Clin Microbiol Infect Dis; 2008 Oct; 27(10):901-6. PubMed ID: 18483755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical impact of Stenotrophomonas maltophilia bacteremia on the 30-day mortality rate in patients with hematologic disorders: a single-institution experience.
    Bao H; Qiao Y; Liu D; Chen J; Wu X; Hu X; Ma X; Wu D
    Infection; 2020 Apr; 48(2):205-212. PubMed ID: 31686323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation.
    Webb BJ; Healy R; Majers J; Burr Z; Gazdik M; Lopansri B; Hoda D; Petersen FB; Ford C
    Clin Infect Dis; 2017 Jun; 64(12):1753-1759. PubMed ID: 28369204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical value of IL-3, IL-4, IL-12p70, IL17A, IFN-γ, MIP-1β, NLR, P-selectin, and TNF-α in differentiating bloodstream infections caused by gram-negative, gram-positive bacteria and fungi in hospitalized patients: An Observational Study.
    Li X; Yuan X; Wang C
    Medicine (Baltimore); 2019 Sep; 98(38):e17315. PubMed ID: 31568018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains.
    Kim EJ; Kim YC; Ahn JY; Jeong SJ; Ku NS; Choi JY; Yeom JS; Song YG
    BMC Infect Dis; 2019 Aug; 19(1):754. PubMed ID: 31462215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal hemorrhagic pneumonia in patients with hematologic diseases and Stenotrophomonas maltophilia bacteremia: a retrospective study.
    Zhu L; Wang L; Zhang Y; Chen R; Li X; Sun J; Zhou D; Zhu M; Zheng X; Li L; Zhu J; Xie M; Yang X; Yu W; Tong H; Zhu H; Xie W; Jin J; Ye X
    BMC Infect Dis; 2021 Jul; 21(1):723. PubMed ID: 34332526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics of Rapidly Progressive Fatal Hemorrhagic Pneumonia Caused by Stenotrophomonas maltophilia.
    Imoto W; Yamada K; Yamairi K; Shibata W; Namikawa H; Yukawa S; Yoshii N; Nakaie K; Hirose A; Koh H; Watanabe T; Asai K; Nakamae H; Kaneko Y; Kawaguchi T; Hino M; Kakeya H
    Intern Med; 2020; 59(2):193-198. PubMed ID: 31941869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive and risk factor analysis for bloodstream infection in high-risk hematological patients with febrile neutropenia: post-hoc analysis from a prospective, large-scale clinical study.
    Okamoto A; Kanda Y; Kimura SI; Oyake T; Tamura K;
    Int J Hematol; 2021 Oct; 114(4):472-482. PubMed ID: 34170481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.